GlobeNewswire
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain
📈
AI Sentiment
Highly Positive
8/10
- Home
- NRXS
NRXS
Neuraxis Inc.
as of 12-05-2025 12:40pm EST
$2.70
$0.01
-0.24%
Stocks Nasdaq
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Chart Type:
Time Range:
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | CARMEL |
| Market Cap: | 25.8M | IPO Year: | 2023 |
| Target Price: | $7.00 | AVG Volume (30 days): | 62.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.01 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.33 - $6.20 | Next Earning Date: | 11-10-2025 |
| Revenue: | $3,362,320 | Revenue Growth: | 36.89% |
| Revenue Growth (this year): | 31.05% | Revenue Growth (next year): | 137.61% |
AI-Powered NRXS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 71.11%
71.11%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Neuraxis Inc. News
NRXS Breaking Stock News: Dive into NRXS Ticker-Specific Updates for Smart Investing
Compare NRXS vs Leading Stocks
See how NRXS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NRXS Neuraxis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.